透過您的圖書館登入
IP:3.145.166.7
  • 期刊
  • OpenAccess

Avoidable Mortality among Long-stay Patients with Schizophrenia under Different Smoking-restriction Settings

摘要


Objective: Patients with schizophrenia are at a greater risk of avoidable death. Although smoking is a modifiable factor to reduce the mortality gap, the rate of quitting smoking in these inpatients is still lower than that in the general population. We examined avoidable mortality among long-stay patients with schizophrenia under different smoking-restriction environments. Methods: A total of 1998 male and 459 female patients with schizophrenia who was admitted to Taipei Veterans General Hospital, Yuli Branch, in Taiwan, received follow-ups for 11 years to be estimated for the standardized mortality ratios (SMRs) of avoidable causes of death. During that period, all the male patients had stayed in smoking-allowed wards, but all the female patients had not. Results: The mean ± standard deviation age of the patients was 57.8 ± 17.0 years. Of the 993 decedents in total, 411 died of avoidable causes (41.4%). Compared with the general population, male patients had significantly higher mortality due to avoidable causes (SMR = 1.96, 95% confidence interval [CI] = 1.77-2.16, p < 0.05) and in terms of indicators of medical care (SMR = 2.41, 95% CI = 2.17-2.67, p < 0.05); however, the female patients did not (SMR = 1.22, 95% CI = 0.67-2.05; SMR = 1.57, 95% CI = 0.86-2.64, respectively). Conclusion: Male patients had higher mortality gaps due to avoidable causes and in terms of indicators of medical care. But female patients who all had stayed in tobacco-free settings did not. Environmental smoking restriction might be related to the diminished avoidable mortality gaps in patients with schizophrenia.

參考文獻


Brown S, Inskip H, Barraclough B: Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212-7.
Cheng KY, Lu TH, Chen TT: Risk factors for natural death in elderly psychiatric male patients with long-stay care. Taiwan J Psychiatry 2015; 29: 40-50.
McCreadie RG; Scottish Schizophrenia Lifestyle Group: diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study. Br J Psychiatry 2003; 183: 534-9.
Felker B, Yazel JJ, Short D: Mortality and medical comorbidity among psychiatric patients: A review. Psychiatr Serv 1996; 47: 1356-63.
Torniainen M, Mittendorfer-Rutz E, Tanskanen A, et al.: Antipsychotic treatment and mortality in schizophrenia. Schizophr Bull 2015; 41: 656-63.

延伸閱讀